Literature DB >> 6154765

Chédiak-Higashi gene in humans I. Impairment of natural-killer function.

T Haliotis, J Roder, M Klein, J Ortaldo, A S Fauci, R B Herberman.   

Abstract

Natural-killer (NK)-cell function was profoundly depressed in donors homozygous for the Chediak-Steinbrinck-Higashi syndrome (C-HS) gene when compared with age- and sex-matched normals. This apparent defect was not simply a result of a delayed response because little cytolysis was evident in kinetics experiments even after 24 h of incubation. NK cells from C-HS donors failed to lyse adherent (MDA, CEM, and Alab) or nonadherent (K562 and Molt-4) tumor cell lines or nontransformed human fetal fibroblasts. Therefore, the apparent C-HS defect was not a result of a shift in target selectivities. In addition, the depressed reactivity did not appear to be a result of suppressor cells or factors because: (a) enriched NK populations (nonadherent lymphocytes bearing receptors for the Fc portion of IgG) from C-HS donors were low in NK-cell function, (b) C-HS mononuclear cells did not inhibit the cytotoxicity of normal cells in coculture experiments, and (c) cells from the C-HS donors remained poorly reactive even after culture for up to 7 d. The nature of the defective NK activity in C-HS patients is not clear but may lie within the lytic mechanism rather than at the level of the recognition structure or population size because the frequency of target-binding cells was normal. In vitro NK activity could be partially restored by interferon treatment. Combined with the results presented in the following paper (4), these observations suggest that the C-HS gene causes a selective immunodeficiency disorder, mainly involving NK cells. This finding, in conjunction with the high incidence of spontaneous possibly malignant, lymphoproliferative disorders in these patients, may have important implications regarding the theory of immune surveillance mediated by NK cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154765      PMCID: PMC2185857          DOI: 10.1084/jem.151.5.1039

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

Review 1.  The Chediak-Higashi syndrome and the homologous trait in animals.

Authors:  D B Windhorst; G Padgett
Journal:  J Invest Dermatol       Date:  1973-06       Impact factor: 8.551

2.  The Chediak-Higashi syndrome: studies in four patients and a review of the literature.

Authors:  R S Blume; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1972-07       Impact factor: 1.889

3.  Enhanced NK cell activity in mice injected with interferon and interferon inducers.

Authors:  M Gidlund; A Orn; H Wigzell; A Senik; I Gresser
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

4.  Target--effector interaction in the natural killer cell system. I. Covariance and genetic control of cytolytic and target-cell-binding subpopulations in the mouse.

Authors:  J C Roder; R Kiessling
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

5.  Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo.

Authors:  O Haller; M Hansson; R Kiessling; H Wigzell
Journal:  Nature       Date:  1977-12-15       Impact factor: 49.962

6.  Chediak-Higashi syndrome. Observations on the nature of the associated malignancy.

Authors:  P B Dent; L A Fish; L G White; R A Good
Journal:  Lab Invest       Date:  1966-10       Impact factor: 5.662

7.  Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes.

Authors:  R K Root; A S Rosenthal; D J Balestra
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

8.  Purification of human monocytes on microexudate-coated surfaces.

Authors:  S K Ackerman; S D Douglas
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

9.  Natural killing in immunodeficient patients.

Authors:  H S Koren; D B Amos; R H Buckley
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

10.  The adherence of human Fc receptor-bearing lymphocytes to antigen-antibody complexes. II. Morphologic alterations induced by the substrate.

Authors:  E Alexander; P Henkart
Journal:  J Exp Med       Date:  1976-02-01       Impact factor: 14.307

View more
  42 in total

1.  Disparate effect of beige mutation on cytotoxic function between natural killer and natural killer T cells.

Authors:  M Bannai; H Oya; T Kawamura; T Naito; T Shimizu; H Kawamura; C Miyaji; H Watanabe; K Hatakeyama; T Abo
Journal:  Immunology       Date:  2000-06       Impact factor: 7.397

2.  Chediak-Higashi syndrome: Lysosomal trafficking regulator domains regulate exocytosis of lytic granules but not cytokine secretion by natural killer cells.

Authors:  Aleksandra Gil-Krzewska; Stephanie M Wood; Yousuke Murakami; Victoria Nguyen; Samuel C C Chiang; Andrew R Cullinane; Giovanna Peruzzi; William A Gahl; John E Coligan; Wendy J Introne; Yenan T Bryceson; Konrad Krzewski
Journal:  J Allergy Clin Immunol       Date:  2015-10-21       Impact factor: 10.793

3.  Cytolytic mechanisms involved in non-MHC-restricted cytotoxicity in Chediak-Higashi syndrome.

Authors:  T Nakazawa; K Agematsu; K Yasui; T Onodera; R Inoue; H Kaneko; N Kondo; M Yamamoto; N Kayagaki; H Yagita; K Okumura; A Komiyama
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

4.  Peripheral blood lymphocytes from thermal injury patients are defective in their ability to generate lymphokine-activated killer (LAK) cell activity.

Authors:  G R Klimpel; D H Herndon; M D Stein
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

Review 5.  Formation and function of the lytic NK-cell immunological synapse.

Authors:  Jordan S Orange
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

6.  Natural killer cell activity in inflammatory joint disease.

Authors:  R D Armstrong; G S Panayi
Journal:  Clin Rheumatol       Date:  1983-09       Impact factor: 2.980

7.  Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumors.

Authors:  N Saijo; E Shimizu; N Irimajiri; A Ozaki; K Kimura; T Takizawa; H Niitani
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

8.  Giant cavernous hemangioma of the liver and multiple primary malignant tumors in a patient with suspected familial inhibition of natural killer cell activity--a case report.

Authors:  T Tomiyama; K Uchida; K Yoshida; T Muto; H Saito; K Nemoto; Z Inoue; T Morita; H Miyakoshi; K Tamura
Journal:  Jpn J Surg       Date:  1989-03

9.  Natural killer cell activity in fawn-hooded rats.

Authors:  J R Starkey; D J Prieur; S S Ristow
Journal:  Experientia       Date:  1983-03-15

10.  Neutropenia in cats with the Chediak-Higashi syndrome.

Authors:  D J Prieur; L L Collier
Journal:  Can J Vet Res       Date:  1987-07       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.